Does ROMIDEPSIN Cause Electrocardiogram qt prolonged? 61 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 61 reports of Electrocardiogram qt prolonged have been filed in association with ROMIDEPSIN (Romidepsin). This represents 4.8% of all adverse event reports for ROMIDEPSIN.
61
Reports of Electrocardiogram qt prolonged with ROMIDEPSIN
4.8%
of all ROMIDEPSIN reports
5
Deaths
3
Hospitalizations
How Dangerous Is Electrocardiogram qt prolonged From ROMIDEPSIN?
Of the 61 reports, 5 (8.2%) resulted in death, 3 (4.9%) required hospitalization, and 2 (3.3%) were considered life-threatening.
Is Electrocardiogram qt prolonged Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROMIDEPSIN. However, 61 reports have been filed with the FAERS database.
What Other Side Effects Does ROMIDEPSIN Cause?
Peripheral t-cell lymphoma unspecified (102)
Nausea (91)
Death (90)
Thrombocytopenia (90)
Pyrexia (77)
Drug ineffective (69)
Anaemia (61)
Platelet count decreased (60)
Vomiting (57)
Fatigue (55)
What Other Drugs Cause Electrocardiogram qt prolonged?
QUETIAPINE (1,869)
OLANZAPINE (1,325)
RIBOCICLIB (1,020)
AMIODARONE (1,000)
HYDROXYCHLOROQUINE (992)
CLOZAPINE (958)
CITALOPRAM HYDROBROMIDE (917)
ESCITALOPRAM OXALATE (899)
ONDANSETRON (881)
BUPROPION (853)
Which ROMIDEPSIN Alternatives Have Lower Electrocardiogram qt prolonged Risk?
ROMIDEPSIN vs ROMIPLOSTIM
ROMIDEPSIN vs ROMOSOZUMAB
ROMIDEPSIN vs ROMOSOZUMAB-AQQG
ROMIDEPSIN vs ROPEGINTERFERON ALFA-2B-NJFT
ROMIDEPSIN vs ROPINIROLE